{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T02:28:09Z","timestamp":1792549689775,"version":"4.5.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T00:00:00Z","timestamp":1765929600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01-AG058676\\u201301A1"],"award-info":[{"award-number":["R01-AG058676\\u201301A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U19AG024904"],"award-info":[{"award-number":["U19AG024904"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GA16788"],"award-info":[{"award-number":["GA16788"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG070941"],"award-info":[{"award-number":["R01AG070941"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Prevention of Alzheimer's Disease"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.tjpad.2025.100455","type":"journal-article","created":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T01:33:14Z","timestamp":1767231194000},"page":"100455","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Plasma A\u03b242\/40 predicts progression from A\u03b2-amyloid negative to positive PET scans"],"prefix":"10.1016","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0826-4011","authenticated-orcid":false,"given":"Azadeh","family":"Feizpour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8051-0558","authenticated-orcid":false,"given":"Vincent","family":"Dor\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2605-4766","authenticated-orcid":false,"given":"Pierrick","family":"Bourgeat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2863-0293","authenticated-orcid":false,"given":"James D.","family":"Doecke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo","family":"Canovas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4355-7082","authenticated-orcid":false,"given":"Simon M.","family":"Laws","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tenielle","family":"Porter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Fowler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph N.","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Maruff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid R.","family":"Sohrabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael W.","family":"Weiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tammie L.S.","family":"Benzinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne E.","family":"Schindler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randall J.","family":"Bateman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1340-6694","authenticated-orcid":false,"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6722-4883","authenticated-orcid":false,"given":"Ovod","family":"Vitaliy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jurgen","family":"Mejan-Fripp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3072-7940","authenticated-orcid":false,"given":"Colin L.","family":"Masters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor L.","family":"Villemagne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3910-2453","authenticated-orcid":false,"given":"Christopher C.","family":"Rowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.tjpad.2025.100455_bib0001","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1001\/jamaneurol.2014.4530","article-title":"Predicting reduction of cerebrospinal fluid \u03b2-amyloid 42 in cognitively healthy controls","volume":"72","author":"Mattsson","year":"2015","journal-title":"JAMA Neurol"},{"issue":"4","key":"10.1016\/j.tjpad.2025.100455_bib0002","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1093\/brain\/aww015","article-title":"Cerebrospinal fluid analysis detects cerebral amyloid-\u03b2 accumulation earlier than positron emission tomography","volume":"139","author":"Palmqvist","year":"2016","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.tjpad.2025.100455_bib0003","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1093\/brain\/aww025","article-title":"Amyloid biomarkers: pushing the limits of early detection","volume":"139","author":"Rabinovici","year":"2016","journal-title":"Brain"},{"issue":"5","key":"10.1016\/j.tjpad.2025.100455_bib0004","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1002\/ana.26891","article-title":"Timing of biomarker changes in sporadic Alzheimer's disease in estimated years from symptom onset","volume":"95","author":"Li","year":"2024","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.tjpad.2025.100455_bib0005","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/s13195-022-01117-1","article-title":"The performance of plasma amyloid beta measurements in identifying amyloid plaques in Alzheimer's disease: a literature review","volume":"14","author":"Brand","year":"2022","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.tjpad.2025.100455_bib0006","series-title":"A-beta metabolism and alzheimer's disease","author":"Saido","year":"2003"},{"issue":"11","key":"10.1016\/j.tjpad.2025.100455_bib0007","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1001\/jamaneurol.2021.3180","article-title":"Head-to-head comparison of 8 plasma amyloid-\u03b2 42\/40 assays in Alzheimer disease","volume":"78","author":"Janelidze","year":"2021","journal-title":"JAMA Neurol"},{"issue":"7691","key":"10.1016\/j.tjpad.2025.100455_bib0008","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/nature25456","article-title":"High performance plasma amyloid-\u03b2 biomarkers for Alzheimer's disease","volume":"554","author":"Nakamura","year":"2018","journal-title":"Nature"},{"issue":"17","key":"10.1016\/j.tjpad.2025.100455_bib0009","doi-asserted-by":"crossref","first-page":"e1647","DOI":"10.1212\/WNL.0000000000008081","article-title":"High-precision plasma \u03b2-amyloid 42\/40 predicts current and future brain amyloidosis","volume":"93","author":"Schindler","year":"2019","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.tjpad.2025.100455_bib0010","doi-asserted-by":"crossref","first-page":"12","DOI":"10.14283\/jpad.2021.70","article-title":"Blood derived amyloid biomarkers for Alzheimer's disease prevention","volume":"9","author":"Udeh-Momoh","year":"2022","journal-title":"J Prev Alzheimers Dis"},{"issue":"11","key":"10.1016\/j.tjpad.2025.100455_bib0011","doi-asserted-by":"crossref","first-page":"8074","DOI":"10.1002\/alz.14315","article-title":"Head-to-head comparison of leading blood tests for Alzheimer's disease pathology","volume":"20","author":"Schindler","year":"2024","journal-title":"Alzheimers Dement"},{"issue":"1","key":"10.1016\/j.tjpad.2025.100455_bib0012","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcaa041","article-title":"Longitudinal evaluation of the natural history of amyloid-\u03b2 in plasma and brain","volume":"2","author":"Burnham","year":"2020","journal-title":"Brain Commun"},{"issue":"S21","key":"10.1016\/j.tjpad.2025.100455_bib0013","doi-asserted-by":"crossref","DOI":"10.1002\/alz.070865","article-title":"TRAILBLAZER-ALZ 3 - a deeper dive into time-to-event trials","volume":"19","author":"Pugh","year":"2023","journal-title":"Alzheimers Dement"},{"issue":"4","key":"10.1016\/j.tjpad.2025.100455_bib0014","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1002\/alz.12748","article-title":"The AHEAD 3-45 Study: design of a prevention trial for Alzheimer's disease","volume":"19","author":"Rafii","year":"2023","journal-title":"Alzheimers Dement"},{"issue":"6","key":"10.1016\/j.tjpad.2025.100455_bib0015","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1001\/jama.2023.13239","article-title":"Donanemab in early symptomatic Alzheimer disease: the TRAILBLAZER-ALZ 2 randomized clinical trial","volume":"330","author":"Sims","year":"2023","journal-title":"JAMA"},{"issue":"228","key":"10.1016\/j.tjpad.2025.100455_bib0016","doi-asserted-by":"crossref","first-page":"228fs13","DOI":"10.1126\/scitranslmed.3007941","article-title":"The A4 Study: stopping AD before symptoms begin?","volume":"6","author":"Sperling","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.tjpad.2025.100455_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.nicl.2019.101800","article-title":"Effect of age, ethnicity, sex, cognitive status and APOE genotype on amyloid load and the threshold for amyloid positivity","volume":"22","author":"Duara","year":"2019","journal-title":"Neuroimage Clin"},{"issue":"1","key":"10.1016\/j.tjpad.2025.100455_bib0018","doi-asserted-by":"crossref","first-page":"443","DOI":"10.3233\/ADR-210005","article-title":"Fifteen years of the Australian Imaging, Biomarkers and Lifestyle (AIBL) study: progress and observations from 2359 older adults spanning the spectrum from cognitive normality to Alzheimer\u2019s disease","volume":"5","author":"Fowler","year":"2021","journal-title":"J Alzheimers Dis Rep"},{"issue":"3","key":"10.1016\/j.tjpad.2025.100455_bib0019","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1212\/WNL.0b013e3181cb3e25","article-title":"Alzheimer's Disease Neuroimaging Initiative (ADNI): clinical characterization","volume":"74","author":"Petersen","year":"2010","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.tjpad.2025.100455_bib0020","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jalz.2016.11.007","article-title":"Recent publications from the Alzheimer's Disease Neuroimaging Initiative: reviewing progress toward improved AD clinical trials","volume":"13","author":"Weiner","year":"2017","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.tjpad.2025.100455_bib0021","article-title":"OASIS-3: longitudinal neuroimaging, clinical, and cognitive dataset for normal aging and Alzheimer disease","author":"LaMontagne","year":"2019","journal-title":"medRxiv 2019"},{"key":"10.1016\/j.tjpad.2025.100455_bib0022","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.cca.2021.05.011","article-title":"The PrecivityAD\u2122 test: accurate and reliable LC-MS\/MS assays for quantifying plasma amyloid beta 40 and 42 and apolipoprotein E proteotype for the assessment of brain amyloidosis","volume":"519","author":"Kirmess","year":"2021","journal-title":"Clin Chim Acta"},{"issue":"7","key":"10.1016\/j.tjpad.2025.100455_bib0023","doi-asserted-by":"crossref","first-page":"e688","DOI":"10.1212\/WNL.0000000000013211","article-title":"Validation of plasma amyloid-\u03b2 42\/40 for detecting Alzheimer disease amyloid plaques","volume":"98","author":"Li","year":"2022","journal-title":"Neurology"},{"key":"10.1016\/j.tjpad.2025.100455_bib0024","series-title":"batchtma: batch effect adjustments","author":"Stopsack","year":"2024"},{"issue":"1","key":"10.1016\/j.tjpad.2025.100455_bib0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jalz.2014.07.003","article-title":"The Centiloid project: standardizing quantitative amyloid plaque estimation by PET","volume":"11","author":"Klunk","year":"2015","journal-title":"Alzheimers Dement"},{"issue":"1","key":"10.1016\/j.tjpad.2025.100455_bib0026","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.neuroimage.2009.01.057","article-title":"Reducing between scanner differences in multi-center PET studies","volume":"46","author":"Joshi","year":"2009","journal-title":"NeuroImage"},{"key":"10.1016\/j.tjpad.2025.100455_bib0027","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.nicl.2018.04.022","article-title":"Utilizing the Centiloid scale in cross-sectional and longitudinal PiB PET studies","volume":"19","author":"Su","year":"2018","journal-title":"Neuroimage Clin"},{"key":"10.1016\/j.tjpad.2025.100455_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2022.119527","article-title":"\u03b2-amyloid PET harmonisation across longitudinal studies: application to AIBL, ADNI and OASIS3","volume":"262","author":"Bourgeat","year":"2022","journal-title":"Neuroimage"},{"key":"10.1016\/j.tjpad.2025.100455_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2020.117593","article-title":"Non-negative matrix factorisation improves Centiloid robustness in longitudinal studies","volume":"226","author":"Bourgeat","year":"2021","journal-title":"NeuroImage"},{"issue":"1","key":"10.1016\/j.tjpad.2025.100455_bib0030","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s13195-020-00587-5","article-title":"Comparison of amyloid PET measured in Centiloid units with neuropathological findings in Alzheimer's disease","volume":"12","author":"Amadoru","year":"2020","journal-title":"Alzheimers Res Ther"},{"issue":"14","key":"10.1016\/j.tjpad.2025.100455_bib0031","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1001\/jama.2020.1267","article-title":"Why test for proportional hazards?","volume":"323","author":"Stensrud","year":"2020","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.tjpad.2025.100455_bib0032","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcab008","article-title":"Detection of \u03b2-amyloid positivity in Alzheimer\u2019s disease neuroimaging initiative participants with demographics, cognition, MRI and plasma biomarkers","volume":"3","author":"Tosun","year":"2021","journal-title":"Brain Commun"},{"issue":"1","key":"10.1016\/j.tjpad.2025.100455_bib0033","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13024-021-00451-6","article-title":"A blood-based diagnostic test incorporating plasma A\u03b242\/40 ratio, ApoE proteotype, and age accurately identifies brain amyloid status: findings from a multi cohort validity analysis","volume":"16","author":"West","year":"2021","journal-title":"Mol Neurodegener"},{"issue":"2","key":"10.1016\/j.tjpad.2025.100455_bib0034","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcad015","article-title":"Plasma amyloid-\u03b242\/40 and apolipoprotein E for amyloid PET pre-screening in secondary prevention trials of Alzheimer\u2019s disease","volume":"5","author":"Cullen","year":"2023","journal-title":"Brain Commun"},{"issue":"2","key":"10.1016\/j.tjpad.2025.100455_bib0035","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1002\/alz.13542","article-title":"Plasma A\u03b242\/A\u03b240 and phospho-tau217 concentration ratios increase the accuracy of amyloid PET classification in preclinical Alzheimer's disease","volume":"20","author":"Rissman","year":"2024","journal-title":"Alzheimers Dement"},{"issue":"1","key":"10.1016\/j.tjpad.2025.100455_bib0036","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/s41398-024-02766-6","article-title":"Characteristics of discordance between amyloid positron emission tomography and plasma amyloid-\u03b2 42\/40 positivity","volume":"14","author":"Pyun","year":"2024","journal-title":"Transl Psychiatry"},{"issue":"5","key":"10.1016\/j.tjpad.2025.100455_bib0037","doi-asserted-by":"crossref","first-page":"e662","DOI":"10.1212\/WNL.0000000000011222","article-title":"Association of \u03b2-amyloid level, clinical progression, and longitudinal cognitive change in normal older individuals","volume":"96","author":"van der Kall","year":"2021","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.tjpad.2025.100455_bib0038","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1007\/s00259-021-05191-9","article-title":"Relationship between amyloid and tau levels and its impact on tau spreading","volume":"48","author":"Dor\u00e9","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"10.1016\/j.tjpad.2025.100455_bib0039","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jalz.2012.12.004","article-title":"Can we prevent Alzheimer's disease? Secondary \u201cprevention\u201d trials in Alzheimer's disease","volume":"9","author":"Carrillo","year":"2013","journal-title":"Alzheimers Dement"},{"issue":"7662","key":"10.1016\/j.tjpad.2025.100455_bib0040","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/547153a","article-title":"Stop Alzheimer\u2019s before it starts","volume":"547","author":"McDade","year":"2017","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.tjpad.2025.100455_bib0041","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/s13311-022-01236-5","article-title":"The current landscape of prevention trials in dementia","volume":"19","author":"Lee","year":"2022","journal-title":"Neurotherapeutics"},{"issue":"5","key":"10.1016\/j.tjpad.2025.100455_bib0042","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/gim.2015.117","article-title":"The genetic landscape of Alzheimer disease: clinical implications and perspectives","volume":"18","author":"Van Cauwenberghe","year":"2016","journal-title":"Genet Med"},{"key":"10.1016\/j.tjpad.2025.100455_bib0043","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105405","article-title":"Detection and staging of Alzheimer's disease by plasma pTau217 on a high throughput immunoassay platform","volume":"109","author":"Feizpour","year":"2024","journal-title":"EBioMedicine"},{"issue":"S2","key":"10.1016\/j.tjpad.2025.100455_bib0044","doi-asserted-by":"crossref","DOI":"10.1002\/alz.091245","article-title":"Assessing the impact of fasting condition and storage time on plasma Amyloid-\u03b2 42 and 40, pTau181, Nf-L and GFAP measurements","volume":"20","author":"Blasco-Forni\u00e9s","year":"2024","journal-title":"Alzheimer's Dementia"},{"issue":"8","key":"10.1016\/j.tjpad.2025.100455_bib0045","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1002\/alz.12510","article-title":"Characterization of pre-analytical sample handling effects on a panel of Alzheimer's disease-related blood-based biomarkers: results from the Standardization of Alzheimer's Blood Biomarkers (SABB) working group","volume":"18","author":"Verberk","year":"2022","journal-title":"Alzheimer's & Dementia"}],"container-title":["The Journal of Prevention of Alzheimer's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580725003966?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580725003966?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T17:46:00Z","timestamp":1778867160000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2274580725003966"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S2274580725003966"],"URL":"https:\/\/doi.org\/10.1016\/j.tjpad.2025.100455","relation":{},"ISSN":["2274-5807"],"issn-type":[{"value":"2274-5807","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasma A\u03b242\/40 predicts progression from A\u03b2-amyloid negative to positive PET scans","name":"articletitle","label":"Article Title"},{"value":"The Journal of Prevention of Alzheimer's Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tjpad.2025.100455","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS on behalf of SERDI Publisher.","name":"copyright","label":"Copyright"}],"article-number":"100455"}}